XENE Earnings

Quarterly EPS
$-0.81
Q3 2024
$-0.84
Q4 2024
$-0.83
Q1 2025
$-1.07
Q2 2025
$-1.15
Q3 2025
$-1.31
Q4 2025
$-1.17
Q1 2026
$-1.11
Q2 2026
Latest RevenueN/A
Latest Net Income-110736000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.110-110736000-3.7%
Q1 2026-$1.170-102302000-100.0%-41.0%
Q4 2025-$1.310-105261000-56.0%
Q3 2025-$1.150-90896000-42.0%
Q2 2025-$1.070-84706000-42.7%
Q1 2025-$0.837.5M-65047000-33.9%
Q4 2024-$0.840-65685000-31.2%
Q3 2024-$0.810-62790000-11.0%
Q2 2024-$0.750-57924000
Q1 2024-$0.620-47931000
Q4 2023-$0.640-44743000
Q3 2023-$0.730-48462000
Xenon Pharmaceuticals (XENE) — Earnings